Valproic acid: a potential role in treating latent HIV infection.
Routy
Jean-Pierre
JP
Division of Hematology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec H3A 1A1, Canada. routyjp@muhchem.mcgill.ca
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D012367:RNA, Viral / Q000097:blood; D014635:Valproic Acid / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D056572:Histone Deacetylase Inhibitors; D012367:RNA, Viral; D014635:Valproic Acid